Semaglutide is the active ingredient in several FDA-approved weight loss medications, including Ozempic and Wegovy
Allergic Reactions: Rare, but some individuals may experience allergic responses
10.1016/j.toxicon.2018.02.049 275 SonD
Women currently taking Ozempic who wish to breastfeed, or those who become pregnant while on treatment, should discuss their options with their GP or diabetes specialist well in advance to ensure a smooth and safe transition
The concomitant improvement in insulin sensitivity and beta-cell function, which were associated with normalization of glucose levels in people with prediabetes, suggests that tirzepatide treatment may delay and potentially halt progression to T2D, by inducing so-called beta-cell rest and ultimately, modifying the natural history of prediabetes/T2D
The Compounded Medication Option: Some telehealth services advertise compounded semaglutide with monthly pricing that varies by provider, dose, and service model